Dermata Therapeutics Quote - DRMA

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

1.27

Bid

1.27

Offer

1.32

Volume

200,611

1.25 Day's Range 1.33

1.00 52 Week Range 13.35

Market Cap

2.592M

Previous Close

1.3562

Open

1.325

Last Trade

1.29

Last Trade Time

Financial Volume

US$ 260,552

VWAP

1.2988

Average Volume (3m)

318,345

Shares Outstanding

2,040,768

Dividend Yield

PE Ratio

-0.35

Earnings Per Share (EPS)

-3.82

Revenue

Net Profit

-7.8M

Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its p... Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.dermatarx.com

Headquarters

Wilmington, Delaware, USA

Founded

Dermata Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker DRMA. The last closing price for Dermata Therapeutics was US$1.36. Over the last year, Dermata Therapeutics shares have traded in a share price range of US$ 1.00 to US$ 13.35.

Dermata Therapeutics currently has 2,040,768 shares in issue. The market capitalisation of Dermata Therapeutics is US$2.77 million. Dermata Therapeutics has a price to earnings ratio (PE ratio) of -0.35.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.19	17.5925925926	1.08	1.41	1.06	604127	1.25696437	CS
4	0.13	11.4035087719	1.14	1.45	1	702368	1.34153788	CS
12	-0.17	-11.8055555556	1.44	1.68	1	318345	1.3632976	CS
26	-1.37	-51.8939393939	2.64	5	1	1441964	2.53530581	CS
52	-7.43	-85.4022988506	8.7	13.35	1	948878	3.97870576	CS
156	-512.33	-99.7527258567	513.6	588	1	957600	66.25621174	CS
260	-1390.73	-99.9087643678	1392	1668	1	890396	113.20660482	CS

DRMA - Frequently Asked Questions (FAQ)

What is the current Dermata Therapeutics share price?

The current share price of Dermata Therapeutics is US$ 1.27

How many Dermata Therapeutics shares are in issue?

Dermata Therapeutics has 2,040,768 shares in issue

What is the market cap of Dermata Therapeutics?

The market capitalisation of Dermata Therapeutics is USD 2.77M

What is the 1 year trading range for Dermata Therapeutics share price?

Dermata Therapeutics has traded in the range of US$ 1.00 to US$ 13.35 during the past year

What is the PE ratio of Dermata Therapeutics?

The price to earnings ratio of Dermata Therapeutics is -0.35

What is the reporting currency for Dermata Therapeutics?

Dermata Therapeutics reports financial results in USD

What is the latest annual profit for Dermata Therapeutics?

The latest annual profit of Dermata Therapeutics is USD -7.8M

What is the registered address of Dermata Therapeutics?

The registered address for Dermata Therapeutics is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808

What is the Dermata Therapeutics website address?

The website address for Dermata Therapeutics is www.dermatarx.com

Which industry sector does Dermata Therapeutics operate in?

Dermata Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
INTZIntrusion Inc	US$ 2.167 (381.56%)	189.59M
AILEiLearningEngines Inc	US$ 0.5932 (267.31%)	563.26M
HUBCWHub Cyber Security Ltd	US$ 0.035 (250.00%)	2.79M
GTIGraphjet Technology	US$ 0.967551 (185.83%)	398.95M
LITMSnow Lake Resources Ltd	US$ 1.61 (82.95%)	131.98M
NEUPNeuphoria Therapeutics Inc	US$ 4.11 (-92.30%)	940.73k
VIRXViracta Therapeutics Inc	US$ 0.16 (-32.49%)	9.47M
PRFXPainReform Ltd	US$ 3.48 (-28.98%)	949.52k
AIREreAlpha Tech Corporation	US$ 2.56 (-28.49%)	8.42M
AVGRAvinger Inc	US$ 0.9721 (-24.05%)	2.16M
AILEiLearningEngines Inc	US$ 0.5932 (267.31%)	563.26M
GTIGraphjet Technology	US$ 0.967551 (185.83%)	398.95M
RGTIRigetti Computing Inc	US$ 17.08 (10.62%)	305.79M
XTIAXTI Aerospace Inc	US$ 0.03935 (-1.63%)	268M
QSIQuantum Si Inc	US$ 3.585 (66.74%)	256.01M